-
Study aim
-
Determining the effect of Noma syrup (Lactuca sativa leaf extract) with clonazepam tablets on the severity of insomnia in hemodialysis patients.
-
Design
-
Clinical trial with control group, 102 patients were randomly assigned to two groups of 51 patients receiving Noma syrup and control (receiving clonazepam tablets) according to the computer program Permuted Block Randomization.
-
Settings and conduct
-
intervention group drink Noma syrup containing 240 ml every night for 20 ml, half an hour before bedtime for two weeks. The drug in the control group is clonazepam tablets, which will be given 0.5 mg of clonazepam tablets every night, half an hour before bedtime, for two weeks to the subjects in the control group. The severity of insomnia with the ISI index is completed before the start of the study and after two weeks of medication. The place of study is the Shahrvand center of Sari city.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: People 18 years and older with insomnia problem, hemodialysis two or three times a week, Iranian nationality, mental alertness, ability to answer questions, no delirium, no cognitive problems, no history of stroke and Incurable diseases such as cancer, no severe hearing and vision problems and substance abuse.
Exclusion criteria: Patients taking anti-anxiety or hypnotic drugs. Patients using accompanying therapies such as acupuncture, herbal remedies, hypnosis or yoga. The patient's unwillingness to continue the study, exacerbation of sleep disorders, delirium, allergic reaction or death of the patient are the exclusion criteria.
-
Intervention groups
-
In the intervention group, Noma syrup is consumed 20 ml every night, 30 minute before going to bed for two weeks. In the control group, clonazepam tablets will be given 0.5 mg of clonazepam tablets every night, 30 minute before bedtime, for two weeks.
-
Main outcome variables
-
Insomnia Severity